Oddway International cuts prices of Lung Cancer Drugs by upto 30-40 %

The idea is to make treatment of critical diseases more affordable as medicines constitute a major part of the total health expenditure, mainly in case of tertiary care. In developing countries, almost 80% of the out-of-pocket expenditure is on medicine, whereas in Developed countries it is around 75%. The new drugs that have been brought under price control will positively impact thousands of patients across the world by making the treatment more affordable.

The company has recently cut the maximum price of major selling lung cancer drugs Erlotinib, Gefitinib and Pemetrexed by about 30-40%.

The company has also reduced prices of a few other cancer drugs as well including commonly used drugs for cancer (brain and breast) and prostate cancer. The move will bring relief for patients suffering from critical diseases.

[b]About Oddway International[/b]

As a worldwide pharmaceutical wholesaler, we are committed to distributing the highest quality products at the best prices. The trusted relationships we have developed with our Authorized Trading Partners allow us to consistently and competitively meet, and exceed, customer needs. Our customers, which include thousands of Hospitals, Pharmacies, and various types of Specialty Centers & clinics, rely on us to support this critical component of patient care, and we treat this responsibility with the highest regard.

[b][i]For more info about us, please visit our site : http://www.gefitinibprice.com[/i][/b]

[b][i]Download Our App On Google Play and IOS also. It takes a maximum 60 second.*[/i][/b]